Andrew von Eschenbach has an excellent piece in the WSJ today about how FDA reform could support innovation.
http://tinyurl.com/83emomv
Andy is a visionary who transformed the National Cancer Institute and then went on to become fine FDA Commissioner under extremely difficult circumstances. He will be chairing MI's Project FDA and we wish him and MI the best of luck in this important endeavor!
As an historical footnote, I was chair of MI's 21st Century FDA Task Force from 2004-6. Peter and I wrote the Task Force report "Prescription for Progress: The Critical Path To Drug Development", which you can find here along with links to articles about Andy's participation in the report's release:
http://www.manhattan-institute.org/html/fda_task_1_members.htm
http://tinyurl.com/83emomv
Andy is a visionary who transformed the National Cancer Institute and then went on to become fine FDA Commissioner under extremely difficult circumstances. He will be chairing MI's Project FDA and we wish him and MI the best of luck in this important endeavor!
As an historical footnote, I was chair of MI's 21st Century FDA Task Force from 2004-6. Peter and I wrote the Task Force report "Prescription for Progress: The Critical Path To Drug Development", which you can find here along with links to articles about Andy's participation in the report's release:
http://www.manhattan-institute.org/html/fda_task_1_members.htm
